Navigation Links
B. Braun Offers Wound Patients a New 'Over-the-Counter' Wound Management Gel - Prontosan®
Date:1/10/2011

BETHLEHEM, Pa., Jan. 10, 2011 /PRNewswire/ -- In its continued effort to advance best practices in wound care management, B. Braun Medical Inc. (B. Braun) announced today that Prontosan® Wound Management Gel with PHMB (Polyhexanide), a product used in the healthcare setting for cleaning wounds as well as moistening and lubricating absorbent wound dressings, is now available for over-the-counter (OTC) use. The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for Prontosan® Wound Management Gel for OTC use in November 2010.

(Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO)

"Effective wound care management no longer needs to be limited to within healthcare facility walls," said Mike Kelly, Director of Marketing, Infection Control Products for B. Braun Medical Inc. "The 510(k) clearance for over-the-counter use of Prontosan® Wound Management Gel advances B. Braun's commitment to infection prevention, helping to provide solutions that positively impact patients' care – in a physician's office, acute care setting or in a patient's home."

Prontosan® aids in the thorough removal of dirt and debris from chronic wounds, skin ulcers and abrasions, even when surfaces are difficult to access (i.e. skin folds, fissures and wound pockets), and can be used to cleanse and soften encrusted wound coatings.

The ready-to-use gel contains PHMB and Betaine, the surfactant for the cleansing and moistening of wounds. PHMB has quickly gained popularity among healthcare professionals as a wound irrigation cleanser. Its non-toxic and biocompatible formula offers excellent skin tolerance.

"Since Prontosan® Wound Management Gel no longer requires a prescription, physicians can rest assured that patients will have access to the easy-to-use wound care product after they are discharged," said David Armstrong, DPM, MD, PhD, Professor of Surgery, University of Arizona.

With a shelf life of 28 days after opening, Prontosan® Wound Management Gel promotes the release of fibrin coatings and residue from wound coatings, and inhibits microorganisms from developing in the product. The gel's PVC-free and DEHP-free product containers also make it environmentally friendly. Prontosan® was originally made available for physician-only use by B. Braun in the fall of 2009.

For more information about Prontosan® Wound Gel with PHMB (Polyhexanide), please call: 1-800-227-2862. To order Prontosan® online, visit www.starmedical-dme.com.  

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.


'/>"/>
SOURCE B. Braun
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Voluntarily Recalls Seven Lots of Heparin Manufactured in 2008 Due to Supplier-Initiated Recall of Heparin Active Pharmaceutical Ingredient (API)
2. B. Braun Wins Third Consecutive Safety IV Catheters Contract Award from Premier, Inc.
3. FDA-Approved Cefepime Now Available for Use in B. Brauns DUPLEX® System
4. B. Braun Customers Gain Premier Access to Zynx Health Device Networks Evidence-based, Customizable Drug Library Program
5. B. Braun Large Volume Heparin Infusion Solutions Now Available
6. New Technology Center Increases B. Brauns Infusion Pump Capacity
7. Health Robotics Re-Acquires CytoCares European Rights from B. Braun Melsungen AG for Undisclosed Consideration
8. FDA Approves Cefepime for Use In B. Brauns DUPLEX(R) System
9. B. Braun Renal Therapies Division Announces Availability of Adimea
10. B. Braun Infusion Systems Complete Interoperability Test for HIMSS10 Interoperability Showcase
11. MEDRAD and B. Braun Melsungen AG Collaborate to Promote Breakthrough Medical Treatment for Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016  While Abbott,s announced purchase ... company,s valve repair and stent business, healthcare research ... Abbott more firmly into patient monitoring.  Kalorama said ... growing device areas, with double-digit growth expected the ... Advanced Remote Patient Monitoring . Abbott ...
(Date:4/28/2016)... 28, 2016  Marking its one year anniversary ... ovarian cancer risk test, Color Genomics ... that highly impact the most common hereditary cancers ... Color Test analyzes hereditary cancer risks for breast, ... cancers. The Color Test is physician ordered and ...
(Date:4/28/2016)... YORK , April 28, 2016  The blood ... 275 million dollars, according to Kalorama Information and The ... typing, immunoassays and nucleic acid testing.  The healthcare research ... made progress in developing blood collection stations and in ... made in Kalorama Information,s report, Blood Testing ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free Certification ... pleased to announce the launch of the GFCP Scoop in response ... The purpose of the GFCP Scoop site is to keep the ...
(Date:4/29/2016)... New York, NY (PRWEB) , ... April 29, 2016 , ... New York City based ... surgery . This surgery is a very effective way to treat obstructive sleep apnea. Dr. ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This ...
(Date:4/29/2016)... GA (PRWEB) , ... April 29, 2016 , ... ... the closing of a growth round of funding led by Eastside Partners, with ... support the company’s rapidly growing customer base and accelerate its technology and product ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... focused entirely on patients with cancer, today announced that Lynne Malestic, RN, of ... 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors nurses who ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
Breaking Medicine News(10 mins):